EN
HI
Summary
As of 19 Sep, 2026, Goldline Pharmaceutical stock price is ₹34.9. During the trading session, the stock has moved between an intraday low of ₹34.22 and an intraday high of ₹35.00. Over the last 52 weeks, Goldline Pharmaceutical has traded between ₹33.00 and ₹60.00.
The stock has recorded a trading volume of 9,000 shares,. Its Average Traded Price (ATP) is ₹34.70, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 3000 @ ₹34.90.
Goldline Pharmaceutical has an upper circuit limit of ₹41.88 and a lower circuit limit of ₹27.92. The total value traded stands at ₹3.12 L, and the delivery percentage for the day is -1%.
The stock is currently traded with a market lot size of 3000. Goldline Pharmaceutical also offers a dividend yield of 0%.
Goldline Pharmaceutical Share Price Chart
Goldline Pharmaceutical Share Key Metrics
Volume
9000.00
Market Cap
33.50 CR
LTQ@LTP
3000@34.90
ATP
34.7
Var Margin
53.5 %
Circuit Range
27.92-41.88
Delivery %
- %
Value
3.12 L
ASM/GSM
No
Market Lot
3000
Goldline Pharmaceutical Resistance and Support
Pivot 36.6
Resistance
First Resistance
36.6
Second Resistance
36.6
Third Resistance
36.6
Support
First Support
36.6
Second Support
36.6
Third Support
36.6
Goldline Pharmaceutical Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 18 2026 | 35 | 34.9 | -4.62% | 35 | 34.22 |
| Tue Sep 15 2026 | 36.59 | 36.59 | 0.25% | 36.59 | 36.59 |
| Fri Sep 11 2026 | 36.5 | 36.5 | -0.68% | 36.5 | 36 |
Goldline Pharmaceutical Corporate Actions
| Date | Agenda |
|---|---|
| 2026-06-09 | Audited Results |
Goldline Pharmaceutical News
Goldline Pharmaceutical Ltd - 544759 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Goldline Pharmaceutical's Promoter and Managing Director, Amol Laxmikant Mujumdar, acquired 60,000 equity shares, increasing his total holding to 29.27%. This transaction, conducted via open market purchase, reflects increased promoter confidence.
Sep 02 2026 11:12:17
Goldline Pharmaceutical Ltd - 544759 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Goldline Pharmaceutical's Promoter and Managing Director, Amol Laxmikant Mujumdar, acquired an additional 18,000 equity shares through open market purchase. This transaction increased his total shareholding by 0.19% to 29.46%.
Sep 02 2026 11:09:57
Read More
Goldline Pharmaceutical Management
| Name | Position |
|---|---|
| Amol Laxmikant Mujumdar | Chairman & Managing Director |
| Swapan Premprakash Khandelwal | Whole Time Director |
Goldline Pharmaceutical FAQs
The Buying Price of Goldline Pharmaceutical share is 34.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Goldline Pharmaceutical stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Goldline Pharmaceutical, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Goldline Pharmaceutical shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Goldline Pharmaceutical shares is 0. Useful to assess the stock's value relative to its book value.
To assess Goldline Pharmaceutical’s valuation compare Sector P/E, P/B which are 61.4 & 1.77 with sector averages, along with growth rates and financial metrics.
The Market Cap of Goldline Pharmaceutical is 33.50 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Goldline Pharmaceutical share price is 60.00 & 33.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Goldline Pharmaceutical belongs to the Miscellaneous sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in GLPL
